Zeo ScientifiX (ZEOX) Net Cash Flow Growth (5y) (2017 - 2026)
Zeo ScientifiX (ZEOX) Net Cash Flow Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 44.59% |
| Jan 31, 2026 | 28.79% |
| Oct 31, 2025 | -18.53% |
| Jul 31, 2025 | -39.41% |
| Apr 30, 2025 | -29.13% |
| Jan 31, 2025 | 45.35% |
| Oct 31, 2024 | -46.15% |
| Jul 31, 2024 | 46.57% |
| Apr 30, 2024 | -42.60% |
| Jan 31, 2024 | -79.92% |
| Oct 31, 2023 | 117.84% |
| Jul 31, 2023 | -93.78% |
| Apr 30, 2023 | -50.05% |
| Jan 31, 2023 | -387.45% |
| Oct 31, 2022 | 151.92% |
| Jul 31, 2022 | 15.85% |
| Apr 30, 2022 | -27.72% |
| Jan 31, 2022 | 20.14% |
| Oct 31, 2021 | 49.85% |
| Jul 31, 2021 | -43.08% |